Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
65.50    1.00 (1.55%)
Bid:
65.10
Ask:
65.50
Spread: 0.40 (0.614%)
Market Cap: $40.74b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Acquisition

17 Nov 2010 12:04

RNS Number : 3448W
Axis Bank Limited
17 November 2010
 

 

Meeting of the Board of Directors of Axis Bank Limited (the "Company")

held on November 17, 2010

 

We wish to inform you that at a meeting of the Board of Directors of the Company ("Board") held today, the Board has considered and unanimously approved the acquisition by Axis Securities and Sales Limited ("ASSL"), a wholly owned subsidiary of the Company, of the financial services business of Enam Securities Private Limited ("Enam"), comprising the businesses of investment banking, equity capital markets, debt capital markets, stock broking (retail and institutional) and initial public offering ("IPO") application financing and loans against shares for the purpose of share acquisitions, distribution of third party products (including broking and commission of mutual funds, equity IPOs, capital gain bonds, fixed deposits, RBI bonds) and other financial products, advisory services in relation to the aforesaid and research, conducted by ESPL directly and through its wholly owned subsidiaries in India and overseas, namely, Enam Securities Direct Pvt. Ltd., Enam International Ltd. (UAE), Enam Securities Europe Limited (UK), Enam Finance Pvt. Ltd. (collectively, the "Enam Financial Services Business") by the Company.

 

The Enam Financial Services Business is proposed to be transferred to ASSL by way of a demerger pursuant to a scheme of arrangement under Sections 391-394 and other applicable provisions of the Companies Act, 1956 between the Company, Enam and ASSL and their respective shareholders and creditors ("Scheme"), which scheme was tabled and approved by the Board at its meeting.

 

In consideration for the demerger, the Board of Directors of the Company has approved that the Company shall issue an aggregate of 1,37,82,600 equity shares of face value Rs. 10 (Rupees Ten Only) each credited as fully paid up in exchange for 24,18,000 equity shares of Rs. 10 (Rupees Ten Only) each fully paid up shares held by the shareholders of Enam ("Share Entitlement Ratio"). The Share Entitlement Ratio has been arrived at based on the valuation report prepared by Haribhakti & Co. and confirmed under a fairness opinion prepared by Macquarie Capital Advisers (India) Pvt. Ltd. submitted to the Board at its meeting.

 

The Scheme is subject to the receipt of necessary approvals under applicable law, including the approval of the shareholders and creditors of the Company, Enam and ASSL and the relevant High Courts and the Reserve Bank of India.

The Board also approved the execution of agreements relating to the Acquisition, including an Implementation Agreement between the Company, ASSL, Enam and the Enam Shareholders, which provides the terms and conditions for the transfer of the Financial Services Business and related matters and a Brand License Agreement licensing the right to use the "Enam" brand to the Company and its affiliates for an agreed period.

 

A joint press release from the parties in relation to the transaction is enclosed.

http://www.rns-pdf.londonstockexchange.com/rns/3448W_-2010-11-17.pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFIFLILDLII
Date   Source Headline
28th Apr 202611:22 amRNSUpdate
28th Apr 202611:20 amRNSChange in SMP
28th Apr 202611:20 amRNSGeneral Update
28th Apr 202611:17 amRNSResults
28th Apr 202611:17 amRNSInvestor Presentation and Press Release
28th Apr 202611:16 amRNSDividend and Fund Raising
28th Apr 202611:13 amRNSAGM Update
4th Feb 202612:09 pmRNSMarket Rumour Verification
27th Jan 202610:48 amRNSOutcome of Board Meeting
26th Jan 20267:52 amRNSResults
19th Jan 20261:45 pmRNSResult of Postal Ballot
14th Jan 20269:55 amRNSGrant of Stock Options
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
29th Dec 20257:00 amRNSUpdate to the Global Medium Term Notes Programme
19th Dec 20257:00 amRNSPostal Ballot Notice
19th Dec 20257:00 amRNSPostal Ballot Notice
18th Dec 20257:00 amRNSChange in Director
26th Nov 20251:32 pmRNSNCD Allotment
26th Nov 20251:13 pmRNSCHANGES IN SENIOR MANAGEMENT - CHIEF RISK OFFICER
26th Nov 20251:11 pmRNSNCD Issuance
15th Oct 20253:08 pmRNSGDR Policy
15th Oct 202511:38 amRNSResults
3rd Oct 20251:31 pmRNSPrior Intimation of Board Meeting
4th Aug 20257:00 amRNSDirectorate Change
25th Jul 20253:11 pmRNSPost AGM intimation
24th Jul 20254:04 pmRNSRevision in Vesting period
18th Jul 20259:18 amRNSChange in Management
17th Jul 202511:57 amRNSResults Q1FY26
16th Jul 20259:38 amRNSESOP Grant
2nd Jul 20252:03 pmRNSBoard Meeting Prior Intimation
27th Jun 20251:16 pmRNSPenalty
27th Jun 20257:25 amRNSBRSR
27th Jun 20257:24 amRNSNotice And Integrated Annual Report
5th Jun 20252:55 pmRNSChange in Director
2nd May 20254:17 pmRNSPostal Ballot Results and Scrutinizers Report
25th Apr 20251:52 pmRNSOutcome of Board Meeting
25th Apr 20251:49 pmRNSChange in Management
24th Apr 20252:25 pmRNSOutcome of Board Meeting
24th Apr 20252:23 pmRNSAnnual Financial Results FY25
15th Apr 20256:26 pmRNSPrior Intimation of Board Meeting
2nd Apr 202510:17 amRNSPostal Ballot Notice
13th Feb 202512:52 pmRNSChange in SMP
13th Feb 202512:49 pmRNSRBI Penalty
3rd Feb 20257:00 amRNSChange in vesting period
31st Jan 20252:24 pmRNSChange in Management
17th Jan 20252:46 pmRNSChange in Management
16th Jan 202511:02 amRNSMiscellaneous (Financial Results Q3FY25)
7th Jan 20257:00 amRNSIntimation of Board Meeting
27th Nov 20245:12 pmRNSIntimation wrt SEBI Interim Order Confirmatory
20th Nov 20247:00 amRNSRating Action by ICRA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.